In last trading session, Cns Pharmaceuticals Inc (NASDAQ:CNSP) saw 4.74 million shares changing hands with its beta currently measuring 1.02. Company’s recent per share price level of $0.10 trading at $0.0 or -0.60% at ring of the bell on the day assigns it a market valuation of $5.74M. That closing price of CNSP’s stock is at a discount of -23800.0% from its 52-week high price of $23.90 and is indicating a premium of 20.0% from its 52-week low price of $0.08. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 13.04 million shares which gives us an average trading volume of 15.46 million if we extend that period to 3-months.
Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information
Upright in the red during last session for losing -0.60%, in the last five days CNSP remained trading in the green while hitting it’s week-highest on Friday, 01/24/25 when the stock touched $0.10 price level, adding 11.43% to its value on the day. Cns Pharmaceuticals Inc’s shares saw a change of -17.11% in year-to-date performance and have moved 4.39% in past 5-day. Cns Pharmaceuticals Inc (NASDAQ:CNSP) showed a performance of -11.60% in past 30-days. Number of shares sold short was 1.14 million shares which calculate 0.04 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 0.5 to the stock, which implies a rise of 80.0% to its current value. Analysts have been projecting 0.5 as a low price target for the stock while placing it at a high target of 0.5. It follows that stock’s current price would drop -400.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -400.0% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 17.98% during past 5 years.
Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders
Insiders are in possession of 1.04% of company’s total shares while institution are holding 0.79 percent of that, with stock having share float percentage of 0.80%. Investors also watch the number of corporate investors in a company very closely, which is 0.79% institutions for Cns Pharmaceuticals Inc that are currently holding shares of the company.
On the other hand, Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024 , the former fund manager was holding 162.18 shares of worth $16185.0 or 0.22% of the total outstanding shares. The later fund manager was in possession of 37.94 shares on Oct 31, 2024 , making its stake of worth around $3786.0 in the company or a holder of 0.05% of company’s stock.
